Conatus Pharma begins phaseII b trial of emricasan in ACLF patients pharmabiz.com Liver transplantation is required in some subjects to improve survival and quality of life. In addition to the phase IIb trial in patients with ACLF, Conatus expects to initiate its planned phase IIb/III clinical trial of emricasan in patients who have ... |
